The Edmond Sun

Business

December 12, 2013

Personal genetic tests face sharper scrutiny after 23andMe

WASHINGTON — 23andMe Inc.'s clash with U.S. regulators over the direct sale of its gene analysis service to consumers signals stiffer oversight of thousands of tests in an industry predicted to increase fivefold in size.

The Personal Genome Test from Google-backed 23andMe gives individuals an analysis of their risk of hundreds of diseases based on DNA data. The Food and Drug Administration's action last month to ban sales of the service suggests the agency is expanding its focus to tests it hadn't regulated, said Jeff Gibbs, an attorney with Hyman Phelps & McNamara in Washington.

Genetic tests are in increasing demand to diagnose or determine disease risk and help make treatment decisions, especially in cancer. Increased regulation is needed to make sure tests like 23andMe's fulfill their claims, said James Evans, a geneticist at the University of North Carolina in Chapel Hill.

"These tests should ultimately have to prove themselves," Evans said in a telephone interview. "They should be forced to gather the evidence that backs up those claims."

Genetic analysis of sick and healthy individuals poses new challenges to insurers and government health programs such as Medicare that pay for medical care. UnitedHealth Group Inc., the biggest U.S. health insurer, said last year that it expects national annual spending on genetic tests to increase fivefold over the next decade to $25 billion.

The industry includes companies such as closely held San Diego-based Pathway Genomics Inc., which was cautioned by the FDA about giving estimates of genetic risk of disease directly to consumers, and now provides them through doctors. A large part of the industry isn't tightly overseen by the agency, including Salt Lake City-based Myriad Genetics Inc., among the biggest providers of genetic breast and ovarian cancer diagnostic services, and many smaller laboratories, such as closely held Ambry Genetics Corp., that offer a variety of genetic tests.

23andMe, based in Mountain View, Calif., said in a statement on its website that the company is committed to working with the FDA to address the agency's concerns. While all marketing of the Personal Genome stopped almost two weeks ago, and 23andMe halted sales of health-related data Dec. 5, some customers said the FDA is interfering with their access to personal health information.

"I want to know my own biology; it's my right," said Lynn Fellman, a multimedia artist in Washington who signed up two years ago with 23andMe. "With 23andMe, I don't have to go to the medical establishment to get this information."

Other clients say 23andMe misled them about the accuracy and validity of its test. A complaint filed Nov. 27 in federal court in San Diego seeks $5 million, saying the Personal Genome Service advertised medical claims without getting appropriate FDA authorization.

The FDA's wider purview may include laboratory developed tests, Gibbs said. These tests examine genes or groups of genes for signs of damage and dangerous inborn variations. Manufacturers typically seek FDA marketing clearance for tests that determine whether a person's cancer is treatable by a certain drug. For example, doctors prescribe skin cancer treatment with Roche Holding's Zelboraf after the patient undergoes an FDA-approved test for a certain mutation in the BRAF gene.

Many labs, however, have developed tests that aren't FDA- approved. Some of the more controversial tests use proprietary formulas to suggest whether cancer patients should receive certain treatments, such as harsher forms of radiation or chemotherapy. FDA Commissioner Margaret Hamburg said in June the agency is working to ensure the validity and accuracy of "'high-risk'' laboratory tests.

''It's an issue that's been percolating for years," Gibbs said in a telephone interview. "This is the policy issue that's most in people's minds."

There are about 3,000 laboratory-developed tests available, and most are monitored by the Centers for Medicare & Medicaid Services, rather than the FDA. CMS requires laboratories only show that the tests are accurate and repeatable, not that they contribute to patient care, as FDA reviews do.

The FDA is preparing guidance for regulating laboratory tests, which is currently in administrative review, Susan Laine, an agency spokeswoman, said in an email. Laine wouldn't say what further action the agency might take in the testing area.

The FDA last month gave its first approval for medical use of next-generation sequencing machines, which laboratories increasingly use to decipher swatches of DNA. One of the approved machines is a product from San Diego-based Illumina Inc., the biggest maker of sequencers, that helps laboratories develop tests for specific medical purposes.

23andMe's direct-to-consumer approach bears little resemblance to laboratory tests that are normally ordered and interpreted by physicians, said Alan Mertz, president of the American Clinical Laboratory Association, an industry group based in Washington.

The FDA doesn't have the authority to regulate laboratory tests, Mertz's group said in a citizen's petition in June. In addition, reining in laboratory tests would stand in the way of patient care, because gaining approval would be too expensive and laborious, the petition said.

The tests "will never generate the financial returns needed to justify the costs of obtaining FDA clearance or approval," the petition said. "Patients served by these tests would be left with no testing options."

1
Text Only
Business
  • Victimized by the 'marriage penalty'

    In a few short months, I'll pass the milestone that every little girl dreams of: the day she swears - before family and God, in sickness and in health, all in the name of love - that she's willing to pay a much higher tax rate.

    April 16, 2014

  • MS_injection well.jpg Agency clarifies earthquake-related misinformation

    A state agency says misinformation related to the debate about the cause of more earthquakes across Central Oklahoma includes oil well types, well numbers and injection pressure.
    The Prague sequence of 2011 along the Wilzetta Fault zone included a significant foreshock, a main shock of magnitude 5.7 and numerous aftershocks. It has been suggested that this sequence represents tremors triggered by fluid injection.
    More recently, earthquakes have been recorded in the vicinity of Jones, Arcadia Lake, Edmond, Guthrie, Langston and Crescent. Regulators and scientists are working together to better understand what’s causing all the shaking.

    April 16, 2014 1 Photo

  • psc 1.jpg City likely to borrow less for PSC due to sky-high tax revenue

    During his State of the City Address Edmond Mayor Charles Lamb made a political announcement — he’s planning on running again for the office.
    Lamb made the comments in the question-and-answer session of his presentation during an Edmond Area Chamber of Commerce luncheon at Rose Creek Golf Course, 17031 N. May Ave.
    Mayor pro tem from 2005-2011, Lamb was elected mayor last year. His long record of service in Edmond includes serving on the City Council from 1993 to 2011.
    The question about if he will run again came from the audience. Lamb alluded to his desire to be around when the Public Safety Center is finished, which will be in the fall of 2015; the next mayoral election will be in the spring of 2015.

    April 15, 2014 1 Photo

  • Dr. Fielding’s variance denied by close vote

    Reverse-angle parking will continue at the 13 N. University Drive office of Dr. Brad Fielding. The Edmond City Council rejected a variance request by the local optometrist to end the city’s pilot project in front of his medical facility.
    Councilman Nick Massey and Councilwoman Victoria Caldwell supported Fielding’s variance request that was dismissed in a 3-2 vote.
    Four parking lines were striped late last year at Fielding’s business after the city opened new bicycle lanes along University. The city cites the safety for bicyclists and motorists who traditionally depart while backing into traffic as the main reasons for introducing reverse-angle parking.

    April 15, 2014

  • brisket2.jpg Food Network show visits Guthrie for ’89er Days

    Guthrie’s annual ’89er Days Celebration provides a variety of activities for people to enjoy including a carnival, rodeo, parade and lots of food vendors.
    This year, visitors at the 84th annual event, which runs Tuesday through Saturday, will notice an added bonus when a film crew from the new television series “Carnival Eats” will be in town filming for its inaugural episode.

    April 15, 2014 1 Photo

  • jc_TOUCH THE CLOUDS.jpg OSBI grounds voted locale for new sculpture

    City staff is working toward an agreement with the Oklahoma State Bureau of Investigation Lab to place the “Touch the Clouds” bronze sculpture on the OSBI grounds on Second Street. The City of Edmond would retain ownership of the artwork.
    The Edmond City Council voted 4-1 this week to allow city staff to negotiate the agreement as soon as possible. Mayor Charles Lamb voted against pursuing the agreement.
    City Councilwoman Victoria Caldwell said she was initially interested in placing the sculpture near the Smith House because of it’s proximity to state Highway 66.

    April 15, 2014 1 Photo

  • 11 file for county offices

    Eleven candidates filed for Oklahoma County races last week with County Assessor Leonard E. Sullivan, 79 of Oklahoma City, re-elected to office without opposition, said Doug Sanderson, secretary of the Oklahoma County Election Board.
    Voters will nominate their party’s candidates on June 24 for the statewide primary election, Sanderson said. A run-off primary election is set for Aug. 26. The statewide general election is scheduled for Nov. 4.

    April 14, 2014

  • Why Facebook is getting into the banking game

    Who would want to use Facebook as a bank? That's the question that immediately arises from news that the social network intends to get into the electronic money business.

    April 14, 2014

  • Rally for Rigs OIPA hosts Rally for the Rigs

    The Oklahoma Independent Petroleum Association this week hosted a “Rally for the Rigs” at the Oklahoma state Capitol.

    April 12, 2014 1 Photo

  • Watch China for the next economic trigger

    For my male readers out there, remember back to your teens and 20s when one of the primary goals was getting a date and finding a girlfriend? Oh come on! You can admit it.  Well imagine how it would have complicated matters if no woman would give you a second thought if you didn’t own property. No, not that old beat up car you drove and sometimes slept in. I mean real property, as in a house.

    April 11, 2014

Stocks